MRSA News
Most Popular MRSA Story
Should Big Pharma snap up Cubist?
Over the past several months of M&A fever, matchmaking has become a standard parlor game in pharma-slash-biotech circles. And now you can all add a new name to your fantasy dealmaking rosters,... Read more...
Latest Headlines
- May 22, 2009
- September 5, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
